Mather Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-130
Closed -$1.72K 1798
2024
Q4
$1.72K Hold
130
﹤0.01% 1559
2024
Q3
$4.36K Hold
130
﹤0.01% 1327
2024
Q2
$2.93K Hold
130
﹤0.01% 1780
2024
Q1
$2.79K Buy
+130
New +$3.08K ﹤0.01% 1478

Other funds holding ANAB

Mather Group's ANAB Position: Q1 2025 in Review

Mather Group sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 130 shares — an estimated $1.72K sold.

Mather Group first reported a position in ANAB in Q1 2024 and held it in 4 quarters. The position peaked at $4.36K in Q3 2024. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

  • Mather Group reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
  • Mather Group sold 130 AnaptysBio shares in Q1 2025, an estimated $1.72K.
  • Mather Group first reported a position in AnaptysBio in Q1 2024 and held it in 4 quarters.
  • Mather Group's AnaptysBio position peaked at $4.36K in Q3 2024.
  • 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Mather Group's 13F filing for Q1 2025, filed 25 Apr 2025.